J. Ferrières, J. Cambou, J. Ruidavets, and J. Pous, Trends in acute myocardial infarction prognosis and treatment in Southwestern France between 1985 and 1990 (The MONICA project-Toulouse), The American Journal of Cardiology, vol.75, issue.17, pp.1202-1207, 1995.
DOI : 10.1016/S0002-9149(99)80762-0

S. Abildstrom, S. Rasmussen, M. Rosén, and M. Madsen, Trends in incidence and case fatality rates of acute myocardial infarction in Denmark and Sweden, Heart, vol.89, issue.5, pp.507-518, 2003.
DOI : 10.1136/heart.89.5.507

M. Mccoll, J. Ellison, I. Greer, R. Tait, and I. Walker, Prevalence of the post-thrombotic syndrome in young women with previous venous thromboembolism, British Journal of Haematology, vol.82, issue.2, 2000.
DOI : 10.1191/135886398666741306

V. Pengo, A. Lensing, M. Prins, A. Marchiori, B. Davidson et al., Incidence of Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism, New England Journal of Medicine, vol.350, issue.22, pp.2257-64, 2004.
DOI : 10.1056/NEJMoa032274

L. Gal, G. Kovacs, M. Carrier, M. Do, K. Kahn et al., Risk of recurrent venous thromboembolism after a first oestrogen-associated episode, Thrombosis and Haemostasis, vol.104, issue.3, pp.498-503, 2010.
DOI : 10.1160/TH09-10-0685

URL : https://hal.archives-ouvertes.fr/hal-00722011

D. Stefano, V. Simioni, P. Rossi, E. Tormene, D. Za et al., The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S, Haematologica, vol.91, issue.5, pp.695-703, 2006.

I. Pabinger, H. Grafenhofer, A. Kaider, P. Kyrle, P. Quehenberger et al., Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis, Journal of Thrombosis and Haemostasis, vol.9, issue.5
DOI : 10.1378/chest.126.3_suppl.627S

P. Prandoni, F. Noventa, A. Ghirarduzzi, V. Pengo, E. Bernardi et al., The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients, Haematologica, vol.92, issue.2, pp.199-205, 2007.
DOI : 10.3324/haematol.10516

M. Nordström, B. Lindblad, D. Bergqvist, and T. Kjellström, A prospective study of the incidence of deep-vein thrombosis within a defined urban population, Journal of Internal Medicine, vol.1, issue.Suppl. 21, pp.155-60, 1992.
DOI : 10.1111/j.1365-2796.1992.tb00565.x

R. White, H. Zhou, and P. Romano, Incidence of Idiopathic Deep Venous Thrombosis and Secondary Thromboembolism among Ethnic Groups in California, Annals of Internal Medicine, vol.128, issue.9, pp.737-777, 1998.
DOI : 10.7326/0003-4819-128-9-199805010-00006

E. Oger, Incidence of venous thromboembolism: a community-based study in Western France
URL : https://hal.archives-ouvertes.fr/hal-00726218

E. Group, Groupe d'Etude de la Thrombose de Bretagne Occidentale, Thromb. Haemost, vol.83, issue.5, pp.657-60, 2000.

G. Plu-bureau, M. Horellou, A. Gompel, and J. Conard, Contraception hormonale et risque thromboembolique veineux??: quand demander une ??tude de l???h??mostase??? Et laquelle???, Gyn??cologie Obst??trique & Fertilit??, vol.36, issue.4, pp.448-54, 2008.
DOI : 10.1016/j.gyobfe.2008.02.006

Ø. Lidegaard, E. Løkkegaard, A. Svendsen, C. Agger, and J. Dinger, Hormonal contraception and risk of venous thromboembolism: national follow-up study Range of published estimates of venous thromboembolism incidence in young women, BMJ. Contraception, vol.33975, issue.5, pp.328-364, 2007.

F. Rosendaal, Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis, Thromb. Haemost, vol.78, issue.1, pp.1-6, 1997.

A. Blanco-molina, J. Trujillo-santos, R. Tirado, I. Cañas, A. Riera et al., Venous thromboembolism in women using hormonal contraceptives. Findings from the RIETE Registry, Thrombosis and Haemostasis, vol.101, issue.3, pp.478-82, 2009.
DOI : 10.1160/TH08-10-0684

URL : https://hal.archives-ouvertes.fr/ujm-00439719

J. Heit, C. Kobbervig, A. James, T. Petterson, K. Bailey et al., Trends in the Incidence of Venous Thromboembolism during Pregnancy or Postpartum: A 30-Year Population-Based Study, Annals of Internal Medicine, vol.143, issue.10, pp.697-706, 2005.
DOI : 10.7326/0003-4819-143-10-200511150-00006

A. Witlin, F. Mattar, G. Saade, V. Hook, J. Sibai et al., Presentation of venous thromboembolism during pregnancy, American Journal of Obstetrics and Gynecology, vol.181, issue.5, pp.1118-1139, 1999.
DOI : 10.1016/S0002-9378(99)70092-X

F. Rosendaal, Venous thrombosis: a multicausal disease, The Lancet, vol.353, issue.9159, pp.1167-73, 1999.
DOI : 10.1016/S0140-6736(98)10266-0

O. Wu, L. Robertson, P. Langhorne, S. Twaddle, G. Lowe et al., Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study, Thrombosis and Haemostasis, vol.94, issue.1, pp.17-25, 2005.
DOI : 10.1160/TH04-11-0759

B. Dahlbäck, M. Carlsson, and P. Svensson, Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C., Proceedings of the National Academy of Sciences, vol.90, issue.3, pp.1004-1012, 1993.
DOI : 10.1073/pnas.90.3.1004

F. Rosendaal, T. Koster, J. Vandenbroucke, and P. Reitsma, High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood, Prothrombin thrombophilia. In GeneRevew(internet)Seattle(WA), pp.1504-1512, 1993.

F. Couturaud, C. Leroyer, and D. Mottier, Risk factors and clinical presentation of venous thromboembolism according to the age of relatives of patients with factor V Leiden, Thrombosis and Haemostasis, vol.99, issue.4, pp.793-797, 2008.
DOI : 10.1160/TH07-12-0720

URL : https://hal.archives-ouvertes.fr/hal-00685465

A. Béclère and C. , syndrome des antiphospholipides et obstétrique Plu-Bureau G,BricaireC. contraception chez la femme à risque, rev Prat Med G, vol.3322, pp.347-53, 1994.

D. Petitti, Combination Estrogen???Progestin Oral Contraceptives, New England Journal of Medicine, vol.349, issue.15, pp.1443-50, 2003.
DOI : 10.1056/NEJMcp030751

M. Gomes and S. Deitcher, Risk of Venous Thromboembolic Disease Associated With Hormonal Contraceptives and Hormone Replacement Therapy, Archives of Internal Medicine, vol.164, issue.18, pp.1965-76, 2004.
DOI : 10.1001/archinte.164.18.1965

M. Canonico, G. Plu-bureau, G. Lowe, and P. Scarabin, Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis, BMJ, vol.336, issue.7655, 2008.
DOI : 10.1136/bmj.39555.441944.BE

URL : https://hal.archives-ouvertes.fr/inserm-01142884

H. Vlieg, A. Helmerhorst, F. Vandenbroucke, J. Doggen, C. Rosendaal et al., The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study Medical Eligibility Criteria for contraceptive use Third generation oral contraceptives and risk of venous thrombosis: meta-analysis, BMJ. BMJ, vol.336339323, issue.397305, pp.1227-1258, 2001.

T. Farley, J. Collins, and J. Schlesselman, Hormonal Contraception and Risk of Cardiovascular Disease, Contraception, vol.57, issue.3, pp.211-241, 1998.
DOI : 10.1016/S0010-7824(98)00019-5

S. Hennessy, J. Berlin, J. Kinman, D. Margolis, S. Marcus et al., Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysis, Contraception, vol.64, issue.2, pp.125-158, 2001.
DOI : 10.1016/S0010-7824(01)00234-7

S. Jick and R. Hernandez, Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data Walker AM. Newer oral contraceptives and the risk of venous thromboembolism, BMJ. Contraception, vol.34257, issue.3, pp.2151-43169, 1998.

J. Dinger, L. Heinemann, and D. Kühl-habich, The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance study on Oral Contraceptives based on 142,475 women-years of observation, Contraception, vol.75, issue.5, pp.344-54, 2007.
DOI : 10.1016/j.contraception.2006.12.019

M. Alhenc-gelas, G. Plu-bureau, S. Guillonneau, J. Kirzin, M. Aiach et al., Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives, Journal of Thrombosis and Haemostasis, vol.103, issue.Suppl. 1, pp.1594-600, 2004.
DOI : 10.1111/j.1538-7836.2004.00894.x

N. Egberg, A. Van-beek, C. Gunnervik, S. Hulkko, E. Hirvonen et al., Effects on the hemostatic system and liver function in relation to Implanon and Norplant. A prospective randomized clinical trial Metabolic effects of contraceptive steroids, Contraception. Rev Endocr Metab Disord, vol.5812, issue.22, pp.93-101, 1998.

W. Junge, U. Mellinger, S. Parke, and M. Serrani, Metabolic and Haemostatic Effects of Estradiol Valerate/Dienogest, a Novel Oral Contraceptive, Clinical Drug Investigation, vol.13, issue.1, pp.31573-84, 2011.
DOI : 10.2165/11590220-000000000-00000

J. Vandenbroucke, J. Rosing, K. Bloemenkamp, S. Middeldorp, F. Helmerhorst et al., Oral Contraceptives and the Risk of Venous Thrombosis, New England Journal of Medicine, vol.344, issue.20, pp.1527-1562, 2001.
DOI : 10.1056/NEJM200105173442007

C. Legnani, G. Palareti, G. Guazzaloca, B. Cosmi, B. Lunghi et al., Venous thromboembolism in young women. Role of thrombophilic mutations and oral contraceptive use, European Heart Journal, vol.23, issue.12, pp.984-90, 2002.
DOI : 10.1053/euhj.2001.3082

S. Française-d-'anesthésie and . De-réanimation, Prévention de la maladie thromboembolique veineuse périopératoire et obstétricale ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions, Obstet Gynecol, vol.52107, issue.6, pp.1453-72, 2005.

S. Kuipers, S. Cannegieter, S. Middeldorp, R. L. Büller, H. Rosendaal et al., The Absolute Risk of Venous Thrombosis after Air Travel: A Cohort Study of 8,755 Employees of International Organisations, PLoS Medicine, vol.57, issue.9, pp.290-54, 2007.
DOI : 10.1371/journal.pmed.0040290.t005

L. Moigne, E. Gueguenc, A. Delluc, E. Nowak, D. Mottier et al., écidive après une MVTE survenue sous contraception oestroprogestative:Quel risque ?Quels facteurs de risque?la Revue de Médecine Interne Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors, Arch. Intern. Med, vol.160, issue.6, pp.769-74, 2000.

W. Lijfering, F. Rosendaal, and S. Cannegieter, Risk factors for venous thrombosis - current understanding from an epidemiological point of view, British Journal of Haematology, vol.29, issue.Suppl. 6, pp.824-857, 2010.
DOI : 10.1111/j.1365-2141.2010.08206.x

M. Levine, J. Hirsh, M. Gent, A. Turpie, J. Weitz et al., Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis, Thromb. Haemost, vol.74, issue.2, pp.606-617, 1995.

S. Eichinger, G. Heinze, L. Jandeck, and P. Kyrle, Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism: The Vienna Prediction Model, Circulation, vol.121, issue.14, pp.1630-1636, 2010.
DOI : 10.1161/CIRCULATIONAHA.109.925214

T. Baglin, R. Luddington, K. Brown, and C. Baglin, Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study, The Lancet, vol.362, issue.9383, pp.523-529, 2003.
DOI : 10.1016/S0140-6736(03)14111-6

M. Cushman, R. Glynn, S. Goldhaber, S. Moll, K. Bauer et al., Hormonal factors and risk of recurrent venous thrombosis: the Prevention of Recurrent Venous Thromboembolism trial, Journal of Thrombosis and Haemostasis, vol.88, issue.10, pp.2199-203, 2006.
DOI : 10.1056/NEJM200411043511919

G. Agnelli, P. Prandoni, M. Santamaria, P. Bagatella, A. Iorio et al., Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis, New England Journal of Medicine, vol.345, issue.3, pp.165-174, 2001.
DOI : 10.1056/NEJM200107193450302

T. Baglin, R. Luddington, K. Brown, and C. Baglin, High risk of recurrent venous thromboembolism in men, Journal of Thrombosis and Haemostasis, vol.350, issue.12, pp.2152-2157, 2004.
DOI : 10.1016/S0140-6736(03)14111-6

E. Oger, K. Lacut, L. Gal, G. Couturaud, F. Guénet et al., Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism: results from the EDITH study: a hospital-based case-control study, Journal of Thrombosis and Haemostasis, vol.3, issue.1, pp.793-802, 2006.
DOI : 10.1378/chest.122.4.1487

URL : https://hal.archives-ouvertes.fr/hal-00689449

C. Kearon, M. Gent, J. Hirsh, J. Weitz, M. Kovacs et al., A Comparison of Three Months of Anticoagulation with Extended Anticoagulation for a First Episode of Idiopathic Venous Thromboembolism, New England Journal of Medicine, vol.340, issue.12, pp.901-908, 1999.
DOI : 10.1056/NEJM199903253401201

G. Palareti, B. Cosmi, C. Legnani, A. Tosetto, C. Brusi et al., -Dimer Testing to Determine the Duration of Anticoagulation Therapy, New England Journal of Medicine, vol.355, issue.17, pp.1780-1789, 2006.
DOI : 10.1056/NEJMoa054444

URL : https://hal.archives-ouvertes.fr/hal-01111279

P. Kyrle, E. Minar, C. Bialonczyk, M. Hirschl, A. Weltermann et al., The risk of recurrent venous thromboembolism in men and women Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial, N. Engl. J. Med. Jun J. Thromb. Haemost, vol.173502, issue.256, pp.2558-63, 2004.

S. Christiansen, S. Cannegieter, T. Koster, J. Vandenbroucke, and F. Rosendaal, Thrombophilia, Clinical Factors, and Recurrent Venous Thrombotic Events, JAMA, vol.293, issue.19, pp.2352-61, 2005.
DOI : 10.1001/jama.293.19.2352

S. Schulman, P. Lindmarker, M. Holmström, G. Lärfars, A. Carlsson et al., Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months, Journal of Thrombosis and Haemostasis, vol.82, issue.4, pp.734-776, 2006.
DOI : 10.1093/eurheartj/ehi018

L. Eischer, S. Eichinger, P. Kyrle, R. Beyth, A. Cohen et al., Age at First Venous Thromboembolism and Risk of Recurrence, Medicine, vol.88, issue.6, pp.366-70, 2009.
DOI : 10.1097/MD.0b013e3181c29e31

R. White, H. Zhou, and P. Romano, Length of Hospital Stay for Treatment of Deep Venous Thrombosis and the Incidence of Recurrent Thromboembolism, Archives of Internal Medicine, vol.158, issue.9, pp.1005-1015, 1998.
DOI : 10.1001/archinte.158.9.1005

J. Heit, D. Mohr, M. Silverstein, T. Petterson, O. Fallon et al., Predictors of Recurrence After Deep Vein Thrombosis and Pulmonary Embolism, Archives of Internal Medicine, vol.160, issue.6, pp.761-769, 2000.
DOI : 10.1001/archinte.160.6.761

B. Cosmi, C. Legnani, A. Tosetto, V. Pengo, A. Ghirarduzzi et al., Sex, age and normal post-anticoagulation D-dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension, Journal of Thrombosis and Haemostasis, vol.115, issue.9, pp.1933-1975, 2010.
DOI : 10.1111/j.1538-7836.2010.03955.x

M. Rodger, S. Kahn, P. Wells, D. Anderson, I. Chagnon et al., Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy, Canadian Medical Association Journal, vol.179, issue.5, pp.417-443, 2008.
DOI : 10.1503/cmaj.080493

URL : https://hal.archives-ouvertes.fr/hal-00685547

J. Heit, M. Silverstein, D. Mohr, T. Petterson, C. Lohse et al., The epidemiology of venous thromboembolism in the community Risk of recurrence after a first venous thromboembolic event in young women, Thromb. Haemost. Laczkovics C Haematologica, vol.86, issue.1, pp.452-63, 2001.

S. Eichinger, G. Hron, C. Bialonczyk, M. Hirschl, E. Minar et al., Overweight, obesity, and the risk of recurrent venous thromboembolism High-density lipoprotein and the risk of recurrent venous thromboembolism. Circulation, Arch. Intern. Med, vol.168115, issue.1512, pp.1678-831609, 2007.

J. Segal, D. Brotman, A. Necochea, A. Emadi, L. Samal et al., Predictive Value of Factor V Leiden and Prothrombin G20210A in Adults With Venous Thromboembolism and in Family Members of Those With a Mutation, JAMA, vol.301, issue.23, pp.2472-85, 2009.
DOI : 10.1001/jama.2009.853

S. Schulman, A. Rhedin, P. Lindmarker, A. Carlsson, G. Lärfars et al., A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism, New England Journal of Medicine, vol.332, issue.25, pp.1661-1666, 1995.
DOI : 10.1056/NEJM199506223322501

G. Hron, S. Eichinger, A. Weltermann, E. Minar, C. Bialonczyk et al., Family History for Venous Thromboembolism and the Risk for Recurrence, The American Journal of Medicine, vol.119, issue.1, pp.50-53, 2006.
DOI : 10.1016/j.amjmed.2005.04.043

J. Douketis, A. Tosetto, M. Marcucci, T. Baglin, B. Cosmi et al., Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families, Thrombophilia, Clinical Factors, and Recurrent Venous Thrombotic Events. JAMA: The Journal of the American Medical Association, pp.813-842031, 2005.

S. Christiansen, W. Lijfering, F. Helmerhorst, F. Rosendaal, and S. Cannegieter, Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event, Journal of Thrombosis and Haemostasis, vol.121, issue.Suppl. 6, 2010.
DOI : 10.1111/j.1538-7836.2010.03994.x

P. Ridker, S. Goldhaber, E. Danielson, Y. Rosenberg, C. Eby et al., Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism, New England Journal of Medicine, vol.348, issue.15, pp.1425-1459, 2003.
DOI : 10.1056/NEJMoa035029

A. Lee, M. Levine, R. Baker, C. Bowden, A. Kakkar et al., Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer, New England Journal of Medicine, vol.349, issue.2, pp.146-53, 2003.
DOI : 10.1056/NEJMoa025313

F. Piovella, L. Crippa, M. Barone, D. Viganò, S. Angelo et al., Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis, Haematologica. J. Thromb. Haemost, vol.879, issue.56, pp.515-221119, 2002.

P. Prandoni, A. Lensing, A. Piccioli, E. Bernardi, P. Simioni et al., Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood, pp.3484-3492, 2002.

S. Murin, P. Romano, and R. White, Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism, Thromb. Haemost, vol.88, issue.3, pp.407-421, 2002.

G. Hron, M. Kollars, B. Binder, S. Eichinger, and P. Kyrle, Identification of Patients at Low Risk for Recurrent Venous Thromboembolism by Measuring Thrombin Generation, JAMA, vol.296, issue.4, pp.397-402, 2006.
DOI : 10.1001/jama.296.4.397

A. Tripodi, C. Legnani, V. Chantarangkul, B. Cosmi, G. Palareti et al., High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism, Journal of Thrombosis and Haemostasis, vol.2, issue.8, pp.1327-1360, 2008.
DOI : 10.1111/j.1538-7836.2008.03018.x

P. Kyrle, E. Minar, M. Hirschl, C. Bialonczyk, M. Stain et al., High plasma levels of factor VIII and the risk of recurrent venous thromboembolism The risk of recurrent venous thromboembolism among patients with high factor IX levels, N. Engl. J. Med. J. Thromb. Haemost, vol.343, issue.7, pp.457-62, 2000.

S. Mcrae, H. Tran, S. Schulman, J. Ginsberg, and C. Kearon, Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet, pp.371-379, 2006.

M. Rodger, S. Kahn, P. Wells, D. Anderson, I. Chagnon et al., Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy, Canadian Medical Association Journal, vol.179, issue.5, pp.417-443, 2008.
DOI : 10.1503/cmaj.080493

URL : https://hal.archives-ouvertes.fr/hal-00685547

G. Agnelli, C. Becattini, and P. Prandoni, Recurrent venous thromboembolism in men and women, N

J. Conard, G. Plu-bureau, N. Bahi, M. Horellou, C. Pelissier et al., Progestogen-only contraception in women at high risk of venous thromboembolism, Contraception, vol.70, issue.6, pp.437-478, 2004.
DOI : 10.1016/j.contraception.2004.07.009

T. Baglin, R. Luddington, K. Brown, and C. Baglin, High risk of recurrent venous thromboembolism in men, Journal of Thrombosis and Haemostasis, vol.350, issue.12, pp.2152-2157, 2004.
DOI : 10.1016/S0140-6736(03)14111-6

H. Autorité and D. Santé, Thrombophilie et grossesse -Prévention des risques thrombotiques maternels et placentaires [Internet]. [cited 2012 Feb 9];Available from

D. Stefano, V. Martinelli, I. Rossi, E. Battaglioli, T. Za et al., The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis, British Journal of Haematology, vol.160, issue.3
DOI : 10.1111/j.1538-7836.2005.01307.x

S. Christiansen, W. Lijfering, F. Helmerhorst, F. Rosendaal, and S. Cannegieter, Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event, Journal of Thrombosis and Haemostasis, vol.121, issue.Suppl. 6, 2010.
DOI : 10.1111/j.1538-7836.2010.03994.x

. Van-hylckama, A. Vlieg, F. Helmerhorst, and F. Rosendaal, The Risk of Deep Venous Thrombosis Associated With Injectable Depot-Medroxyprogesterone Acetate Contraceptives or a Levonorgestrel Intrauterine Device, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.30, issue.11, pp.2297-300, 2010.
DOI : 10.1161/ATVBAHA.110.211482

M. Gall, La contraceptionprogestatives après un prmier épisode thromboembolique veineux=étude de cohorte, 2011.

W. Ho, G. Hankey, D. Quinlan, and J. Eikelboom, Risk of Recurrent Venous Thromboembolism in Patients With Common Thrombophilia, Archives of Internal Medicine, vol.166, issue.7, pp.729-765, 2006.
DOI : 10.1001/archinte.166.7.729

J. Vandenbroucke, F. Van-der-meer, F. Helmerhorst, and F. Rosendaal, Factor V Leiden: should we screen oral contraceptive users and pregnant women?, BMJ, vol.313, issue.7065, pp.1127-1157, 1996.
DOI : 10.1136/bmj.313.7065.1127

A. Therapy, Antithrombotic Therapy and Prevention of Thrombosis, Chest, p.2012

A. Sultan, J. West, L. Tata, K. Fleming, C. Nelson-piercy et al., Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study, British Journal of Haematology, vol.107, issue.3, p.2012
DOI : 10.1111/j.1365-2141.2011.08956.x

N. Van-tilburg, F. Rodendaal, and R. Bertina, Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis, Blood, vol.95, pp.2855-2864, 2000.

J. Meijers, S. Middeldorp, and W. Tekelenburg, Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI -independent down regulation of fibrinolysis:a randomized cross-over study of two low-dose oral contraceptives, Thromb Haemost, vol.84, pp.9-14, 2000.

C. Moreau, J. Trussell, F. Gilbert, N. Bajos, and J. Bouyer, Oral Contraceptive Tolerance, Obstetrics & Gynecology, vol.109, issue.6, pp.1277-85, 2007.
DOI : 10.1097/01.AOG.0000260956.61835.6d

URL : https://hal.archives-ouvertes.fr/inserm-00153793